Innoviva Inc. Achieves FDA Priority Review for Breakthrough Gonorrhea Treatment Zoliflodacin
Innoviva Inc.’s subsidiary has achieved a milestone in the fight against gonorrhea with the FDA’s acceptance of a new antibiotic, zoliflodacin, for Priority Review.
2 minutes to read